This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego
BOOK NOW
Menu
BOOK NOW

Dr. Justin Killebrew, PhD
Vice President of Biology at Bonum Therapeutics
Speaker

Profile

Dr. Justin Killebrew is Vice President of Biology at Bonum Therapeutics, bringing over 15 years of experience in oncology and immunology innovation. He joined Good Therapeutics in 2018 and transitioned to Bonum following Good’s acquisition by Roche in 2022. Previously, he led discovery biology at Silverback Therapeutics and advanced immunotherapy programs at Bristol-Myers Squibb. Dr. Killebrew holds a Ph.D. in Immunology from the University of Washington.

Agenda Sessions

  • Conditional Protein Therapeutics using Dual-Binding Antibodies

    , 10:30am
    View Session

At this event

Prev
Next
Jee Kim, PhD
Executive Director of Therapeutic
Regeneron Pharmaceuticals

See Justin at Antibody Engineering & Therapeutics US

BOOK NOW